A systematic review evaluated microRNA-31 (miR-31-3p and miR-31-5p) as a potential predictive biomarker for cetuximab efficacy in metastatic CRC, even among RAS wild-type patients where response variability remains high. (Clin Transl Oncol)
MiR-31 as Predictive Biomarker for Cetuximab Response
The CRC Digest